This was supported by the results in PHF8 inhibitor daminozide-treated human- and murine-derived CRC cells (Fig. 4D-E) as well as daminozide-treated allograft tumor tissues (Fig. 4F). This evidence concerns the gene PHF8 and colorectal carcinoma.